SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899923-22-000112
Filing Date
2022-07-27
Accepted
2022-07-27 16:11:18
Documents
15
Period of Report
2022-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mygn-20220726.htm   iXBRL 8-K 42770
2 EX-10.1 creditagreementforamendmen.htm EX-10.1 1365119
6 image_1.jpg GRAPHIC 1876
7 image_2a.jpg GRAPHIC 2396
  Complete submission text file 0000899923-22-000112.txt   1781269

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20220726.xsd EX-101.SCH 1884
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20220726_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20220726_pre.xml EX-101.PRE 12496
9 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20220726_htm.xml XML 10834
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 221111135
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences